ArgusEye AB
PrivateLast Round
Early Funding
Apr 24, 2026
Total Funding Raised
$10.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ArgusEye AB is a biotechnology company that develops nanoplasmonic biosensor solutions for real-time monitoring of biological systems and processes in the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Sensors, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArgusEye AB Comparables
Compare ArgusEye AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck | 74% | |
| 908 Devices Inc. | 73% | |
| IDEX Corp | 73% | |
ArgusEye AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 24, 2026 | ||||
| Grant | Feb 18, 2026 | ||||
| Accelerator | Feb 18, 2026 | ||||
| Seed | May 13, 2024 | ||||
| Seed | Dec 6, 2021 |
Key People
Founding team and executive leadership
ArgusEye AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Accelerator |
| Almi Invest AB | Seed |
| Eir Ventures | Early Funding, Seed |
| Voima Ventures | Early Funding, Seed |
| Impilo | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Feb 18, 2026
Secured $3M from the European Innovation Council.
ArgusEye AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArgusEye AB's valuation, stock price, and market status.